Can anyone tell me more about the potential for revenue from the Serum Albuminum product(s) that GTCB is currently marketting ..... and also what is the regulatory position here ?
To me it does look like that, GTCB must give serious consideration to a PIPE prior to EMEA approval. But I would imagine it would be at prices no worse than today's.
TiA
"....on the biotech battle-field, you need some élan...."